Clinical Trials Browser

Phase 2 × dostarlimab × 30 days × Clear all

NCT05723562 2026-05-26

AZUR-1

Phase 2 Active not recruiting

Gastrointestinal

Rectal Neoplasms

NCT06062420 2026-05-22

A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT06567782 2026-05-22

AZUR-4

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms